Literature DB >> 11448083

Validity and sensitivity of a pen computer battery of performance tests.

E Cameron1, W Sinclair, B Tiplady.   

Abstract

This study compared administration of performance tests and visual analogue scales (VAS) using a newly developed pen computer (PenC) battery with established tests using either pencil-and-paper (PP) or conventional computer. The performance of 47 subjects (23 male, age 18-45 years, weight 51-112 kg) was compared on the two systems after a dose of ethanol (0.8 g/kg up to a maximum of 60 g for males, 50 g for females) or placebo in a double-blind two-period randomized crossover study. Mean (SD) blood ethanol concentrations (breathalyser) were 94.5 mg/100 ml (21.9) at the start of the test battery (30 min post-drink) and 80.2 (13.0) at the end of the battery (75 min post-drink). Ethanol effects were found in all tests, with most outcome measures showing significant slowing or loss of accuracy. Results from the Rapid Visual Information Processing, Sentence Verification and Continuous Attention tasks show that the ethanol-placebo difference and the statistical significance of this difference are in close correspondence for the two modes of administration. The pen computer versions of these tasks may therefore be used as direct replacements for the previous versions. Digit-Symbol and maze tasks did not correspond so closely both showing differences in the speed-accuracy trade-off between the two modes. These tests, however, are sensitive to the effects of ethanol, and may be useful in their own right. Principal component analysis suggested that VAS may be grouped into two factors: (1) 'functional integrity', including measures of alertness and perceived proficiency, and (2) 'mood', including happiness and sociability. Factor 1 showed substantial effects of ethanol, while factor 2 was unchanged. There was close agreement between the results from PP and PenC for both factors as well as for the Sober-Drunk scale, which showed the expected effects of ethanol. Thus pen computer VAS perform in a similar way to the PP versions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11448083     DOI: 10.1177/026988110101500207

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  12 in total

Review 1.  Functional biomarkers for the acute effects of alcohol on the central nervous system in healthy volunteers.

Authors:  Remco W M Zoethout; Wilson L Delgado; Annelies E Ippel; Albert Dahan; Joop M A van Gerven
Journal:  Br J Clin Pharmacol       Date:  2011-03       Impact factor: 4.335

2.  Acceptability and feasibility of a visual working memory task in an ecological momentary assessment paradigm.

Authors:  Randi Melissa Schuster; Robin J Mermelstein; Donald Hedeker
Journal:  Psychol Assess       Date:  2015-04-20

3.  Electronic data capture using the Womac NRS 3.1 Index (m-Womac): a pilot study of repeated independent remote data capture in OA.

Authors:  Nicholas Bellamy; B Patel; T Davis; S Dennison
Journal:  Inflammopharmacology       Date:  2010-04-27       Impact factor: 4.473

4.  Can an app help identify psychomotor function impairments during drinking occasions in the real world? A mixed-method pilot study.

Authors:  Brian Suffoletto; Akash Goyal; Juan Carlos Puyana; Tammy Chung
Journal:  Subst Abus       Date:  2017 Oct-Dec       Impact factor: 3.716

5.  The influence of acute and chronic alcohol consumption on response time distribution in adolescent rhesus macaques.

Authors:  M Jerry Wright; Sophia A Vandewater; Michael A Taffe
Journal:  Neuropharmacology       Date:  2013-01-12       Impact factor: 5.250

6.  Effects of acute insulin-induced hypoglycaemia on psychomotor function: people with type 1 diabetes are less affected than non-diabetic adults.

Authors:  J Geddes; I J Deary; B M Frier
Journal:  Diabetologia       Date:  2008-08-16       Impact factor: 10.122

7.  The effects of energy drink in combination with alcohol on performance and subjective awareness.

Authors:  Chris Alford; Jennifer Hamilton-Morris; Joris C Verster
Journal:  Psychopharmacology (Berl)       Date:  2012-03-29       Impact factor: 4.530

8.  Study protocol: a dose-escalating, phase-2 study of oral lisdexamfetamine in adults with methamphetamine dependence.

Authors:  Nadine Ezard; Adrian Dunlop; Brendan Clifford; Raimondo Bruno; Andrew Carr; Alexandra Bissaker; Nicholas Lintzeris
Journal:  BMC Psychiatry       Date:  2016-12-01       Impact factor: 3.630

9.  Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol.

Authors:  Anjali K Bhardwaj; David J Allsop; Jan Copeland; Iain S McGregor; Adrian Dunlop; Marian Shanahan; Raimondo Bruno; Nghi Phung; Mark Montebello; Craig Sadler; Jessica Gugusheff; Melissa Jackson; Jennifer Luksza; Nicholas Lintzeris
Journal:  BMC Psychiatry       Date:  2018-05-18       Impact factor: 3.630

10.  LiMA: a study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence.

Authors:  Nadine Ezard; Adrian Dunlop; Michelle Hall; Robert Ali; Rebecca McKetin; Raimondo Bruno; Nghi Phung; Andrew Carr; Jason White; Brendan Clifford; Zhixin Liu; Marian Shanahan; Kate Dolan; Amanda L Baker; Nicholas Lintzeris
Journal:  BMJ Open       Date:  2018-07-19       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.